Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide

Among the gynecological malignancies, ovarian cancer is the leading cause of mortality in developed countries. Treatment of ovarian cancer is based on surgery integrated with chemotherapy. Platinum-based drugs (cisplatin and carboplatin) comprise the core of first-line chemotherapy for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Serpe, Loredana, Gallicchio, Margherita, Canaparo, Roberto, Dosio, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917542/
https://www.ncbi.nlm.nih.gov/pubmed/24516337
http://dx.doi.org/10.2147/PGPM.S58374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917542/
https://www.ncbi.nlm.nih.gov/pubmed/24516337
http://dx.doi.org/10.2147/PGPM.S58374

Ejemplares similares